<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-LEN7IZZ4</identifier><date>2018</date><creator>Ocvirk, Janja</creator><relation>documents/doc/L/URN_NBN_SI_doc-LEN7IZZ4_001.pdf</relation><relation>documents/doc/L/URN_NBN_SI_doc-LEN7IZZ4_001.txt</relation><format format_type="issue">2</format><format format_type="volume">22</format><format format_type="type">article</format><format format_type="extent">str. 20-25</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">3137403</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-LEN7IZZ4</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">karcinom Merklovih celic</subject><subject language_type_id="slv">kemoterapija</subject><subject language_type_id="slv">nemelanomski kožni rak</subject><subject language_type_id="slv">razsejana bolezen</subject><title>Karcinom Merklovih celic - novosti v sistemskem zdravljenju</title><title>Merkel cell carcinoma - innovations in systemic treatment</title></Record>